Patents Represented by Attorney, Agent or Law Firm Jennifer Wahlston
  • Patent number: 6306425
    Abstract: An injectable slow-release naltrexone formulation is provided comprising naltrexone in a poly(D,L-lactide) matrix with a small amount of residual ethyl acetate. Upon intramuscular injection of the composition, naltrexone is released in a controlled manner over an extended period of time. The composition finds use in the treatment of heroin addicts and alcoholics to reduce consumption of the abused substances.
    Type: Grant
    Filed: April 7, 2000
    Date of Patent: October 23, 2001
    Assignee: Southern Research Institute
    Inventors: Thomas R. Tice, Jay K. Staas, Teresa M. Ferrell